IPCALAB · IPCA Laboratories Limited · Financials
Volume · Nov 12
9634
Avg daily vol (3M)
40.73K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
96.46B
+7.9%
FY2026
Net Income
11.41B
+54.7%
FY2026
Operating Cash Flow
11.42B
-13.6%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|---|
| INR | 104.79B | 96.46B | 89.4B | 77.05B | 62.44B | 58.3B | 54.2B | 46.49B |
| INR | 4.4B | 4.18B | 3.98B | 3.57B | 2.62B | 2.32B | 2.09B | 2.11B |
| INR | 622.7M | 759.4M | 849.3M | 1.38B | 455.4M | 76.9M | 90.4M | 165M |
| INR | 4.82B | 3.81B | 3.44B | 3.13B | 2.53B | 2.24B | 2.4B | 1.35B |
| INR | 14.02B | 11.41B | 7.38B | 5.47B | 4.71B | 8.84B | 11.4B | 6.06B |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 4.08B in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.